5IUG
Crystal Structure of Anaplastic Lymphoma Kinase (ALK) in complex with 5a
Summary for 5IUG
Entry DOI | 10.2210/pdb5iug/pdb |
Related | 5IUH 5IUI |
Descriptor | ALK tyrosine kinase receptor, N-[3-(4-{[(5-tert-butyl-1,2-oxazol-3-yl)carbamoyl]amino}-3-methylphenyl)-1H-pyrazol-5-yl]-4-[(4-methylpiperazin-1-yl)methyl]benzamide (3 entities in total) |
Functional Keywords | catalytic domain, transferase |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 1 |
Total formula weight | 37403.89 |
Authors | |
Primary citation | Tu, C.H.,Lin, W.H.,Peng, Y.H.,Hsu, T.,Wu, J.S.,Chang, C.Y.,Lu, C.T.,Lyu, P.C.,Shih, C.,Jiaang, W.T.,Wu, S.Y. Pyrazolylamine Derivatives Reveal the Conformational Switching between Type I and Type II Binding Modes of Anaplastic Lymphoma Kinase (ALK). J.Med.Chem., 59:3906-3919, 2016 Cited by PubMed: 27031565DOI: 10.1021/acs.jmedchem.6b00106 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.93 Å) |
Structure validation
Download full validation report